Tamara Imfeld-Isenegger

Ms. Tamara Imfeld-Isenegger


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
TITamara Imfeld-Isenegger
Tamara Imfeld-Isenegger
ISInês Branco Soares
Inês Branco Soares
UMUrska Nabergoj Makovec
Urska Nabergoj Makovec
NHNejc Horvat
Nejc Horvat
MKMitja Kos
Mitja Kos
Kurt E. HersbergerKurt E. Hersberger
Kurt E. Hersberger

1 January 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
ISInês Branco Soares
Inês Branco Soares
TITamara Imfeld-Isenegger
Tamara Imfeld-Isenegger
UMUrska Nabergoj Makovec
Urska Nabergoj Makovec
NHNejc Horvat
Nejc Horvat
MKMitja Kos
Mitja Kos
FCFilipa Costa
Filipa Costa

21 December 2018 in Pharmacy
Verified
Journal Article
Open access
PDF file
KMKaren A. Maes
Karen A. Maes
JRJasmine A. Ruppanner
Jasmine A. Ruppanner
TITamara Imfeld-Isenegger
Tamara Imfeld-Isenegger
Kurt E. HersbergerKurt E. Hersberger
Kurt E. Hersberger
MLMarkus L. Lampert
Markus L. Lampert
FBFabienne Boeni
Fabienne Boeni
Background: Patient counselling and addressing drug-related problems are the pharmacist’s key activities to ensure the safe and effective use of medicines. This study aimed to describe the dispensing practice of prescribed medicines in daily community pharmacy practice and to identify factors influencing counselling provision; Methods: An observational study was conducted in community pharmacies in Basel, Switzerland. One master student in pharmacy performed non-participatory observations for one day at each of the participating community pharmacies. Patient characteristics, counselling content, additional activities, and pharmaceutical interventions were documented on a structured checklist; Results: 556 prescription encounters (PE) in 18 participating community pharmacies were observed (269 first prescriptions; 287 refill prescriptions). Patients were regular customers (n = 523, 94.1%) and 53.8 ± 23.4 years old. Counselling was provided to 367 (66.0%) customers on 2.9 ± 3.1 themes per PE. Factors influencing counselling were dispensing by the pharmacist, new customer, customer who did not refuse counselling, customer with a first prescription, with a prescription resulting in a pharmaceutical intervention, and a prescription filled by carers. During 144 PEs, 203 interventions were documented. Pharmacists proposed few additional activities and performed no cognitive pharmaceutical service; Conclusions: Our study quantified counselling and additional services at the dispensing of prescribed medicines and identified influencing factors on counselling provision at the patient, prescription, and pharmacy level.

1 November 2021 in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
Verified
Journal Article
Open access
TITamara Imfeld-Isenegger
Tamara Imfeld-Isenegger
HSHelene Studer
Helene Studer
MCMarco Giacomo Ceppi
Marco Giacomo Ceppi
CRChristoph Rosen
Christoph Rosen
MBMichael Bodmer
Michael Bodmer
MLMarkus L. Lampert
Markus L. Lampert
Hospital stays are often associated with medication changes, which may lead to drug-related problems (DRPs). Medication reconciliation and medication reviews are strategies to detect and resolve DRPs. A descriptive cohort study was conducted using DRPs collected during routine pharmacist-led medication reconciliation and medication reviews in the hospital's community pharmacy at discharge (Zug Cantonal Hospital, Switzerland). In a simulation experiment, we retrospectively analysed the detection and resolution possibilities of these DRPs and their dependency on different information sources. Overall, 6,087 prescriptions were filled in the hospital's community pharmacy (between June 2016 and May 2019). Among 1,352 prescriptions (with ≥ 1 documented DRP) a total of 1,876 DRPs were detected. The retrospective assessment showed that 1,115 DRPs could have been detected by performing simple medication reviews (based on the discharge prescription and the medication history), whereas in the remaining cases, additional clinical and/or patient-specific information would have been needed. In 944 (84.7 %) DRPs, which are detectable by simple medication reviews, the pharmacist would need to consult the prescriber for resolution. The detection of DRPs is strongly influenced by the information available. These results support models with pre-discharge medication reconciliation and pharmacist-led medication review procedures enabling both comprehensive detection and facilitated resolution of DRPs.

9 March 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
TITamara Imfeld-Isenegger
Tamara Imfeld-Isenegger
MPMelanie Bich Tram Pham
Melanie Bich Tram Pham
Dominik StämpfliDominik Stämpfli
Dominik Stämpfli
VAValerie Albert
Valerie Albert
EAEnas Almanasreh
Enas Almanasreh
Kurt E. HersbergerKurt E. Hersberger
Kurt E. Hersberger
Background: Transitions of care are high-risk situations for the manifestation of medication discrepancies and, therefore, present threats for potential patient harm. Medication discrepancies can occur at any transition within the healthcare system. Methods: Fifth-year pharmacy students assessed a best possible medication list (BPML) during a medication review (based on medication history and patient interview) in community pharmacies. They documented all discrepancies between the BPML and the latest medication prescription. Discrepancies were classified using the medication discrepancy taxonomy (MedTax) classification system and were assessed for their potential clinical and economic impact. Results: Overall, 116 patients with a mean age and medication prescription of 74 (± 10.3) years and 10.2 (± 4.2), respectively, were analyzed. Of the 317 discrepancies identified, the most frequent type was related to strength and/or frequency and/or number of units of dosage form and/or the total daily dose. Although, the majority of discrepancies were rated as inconsequential (55.2%) on health conditions, the remainder posed a potential moderate (43.2%) or severe impact (1.6%). In 49.5% of the discrepancies, the current patients’ medication cost less than the prescribed. Conclusion: Community pharmacies are at a favorable place to identify discrepancies and to counsel patients. To improve patient care, they should systematically perform medication reconciliation whenever prescriptions are renewed or added.